Evolent Health (NYSE:EVH) Reaches New 1-Year Low – Time to Sell?

Evolent Health, Inc. (NYSE:EVH)’s share price reached a new 52-week low on Thursday . The company traded as low as $9.93 and last traded at $10.01, with a volume of 6957802 shares trading hands. The stock had previously closed at $11.18.

Analyst Upgrades and Downgrades

EVH has been the topic of a number of research reports. Royal Bank of Canada lowered their price target on shares of Evolent Health from $20.00 to $17.00 and set an “outperform” rating on the stock in a report on Tuesday. Stephens downgraded Evolent Health from an “overweight” rating to an “equal weight” rating and cut their price target for the stock from $38.00 to $16.00 in a research note on Friday, November 8th. JPMorgan Chase & Co. lowered their price objective on Evolent Health from $45.00 to $15.00 and set an “overweight” rating on the stock in a research note on Friday, November 22nd. Citigroup cut their target price on shares of Evolent Health from $21.00 to $18.00 and set a “buy” rating for the company in a research report on Friday, January 10th. Finally, JMP Securities dropped their price target on shares of Evolent Health from $27.00 to $18.00 and set a “market outperform” rating on the stock in a research note on Friday, January 10th. One equities research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $22.58.

Evolent Health Stock Down 10.5 %

The company has a 50 day moving average of $12.44 and a 200-day moving average of $20.92. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.04 and a quick ratio of 1.04. The company has a market cap of $1.17 billion, a P/E ratio of -11.00 and a beta of 1.45.

Institutional Trading of Evolent Health

A number of large investors have recently modified their holdings of the business. Covestor Ltd raised its stake in Evolent Health by 138.1% in the third quarter. Covestor Ltd now owns 1,424 shares of the technology company’s stock valued at $40,000 after purchasing an additional 826 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Evolent Health by 5,365.5% in the 3rd quarter. GAMMA Investing LLC now owns 1,585 shares of the technology company’s stock worth $45,000 after buying an additional 1,556 shares during the last quarter. Quarry LP purchased a new stake in shares of Evolent Health during the 2nd quarter valued at $32,000. Canada Pension Plan Investment Board bought a new stake in shares of Evolent Health during the 2nd quarter worth $61,000. Finally, Quest Partners LLC purchased a new position in Evolent Health in the second quarter worth $87,000.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.